BlackRock Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$88K Sell
18,942
-738
-4% -$3.43K ﹤0.01% 3010
2016
Q3
$152K Buy
19,680
+1,549
+9% +$12K ﹤0.01% 2764
2016
Q2
$110K Buy
18,131
+2,296
+14% +$13.9K ﹤0.01% 2872
2016
Q1
$135K Sell
15,835
-422
-3% -$3.6K ﹤0.01% 2719
2015
Q4
$194K Sell
16,257
-7,116
-30% -$84.9K ﹤0.01% 2551
2015
Q3
$236K Buy
23,373
+328
+1% +$3.31K ﹤0.01% 2591
2015
Q2
$382K Buy
23,045
+5,202
+29% +$86.2K ﹤0.01% 2339
2015
Q1
$276K Buy
17,843
+3,191
+22% +$49.4K ﹤0.01% 2461
2014
Q4
$232K Buy
14,652
+1,141
+8% +$18.1K ﹤0.01% 2509
2014
Q3
$144K Buy
13,511
+3,660
+37% +$39K ﹤0.01% 2769
2014
Q2
$93K Buy
9,851
+227
+2% +$2.14K ﹤0.01% 3052
2014
Q1
$66K Buy
9,624
+2,114
+28% +$14.5K ﹤0.01% 3160
2013
Q4
$29K Buy
7,510
+366
+5% +$1.41K ﹤0.01% 3306
2013
Q3
$36K Buy
7,144
+1,457
+26% +$7.34K ﹤0.01% 3235
2013
Q2
$36K Buy
+5,687
New +$36K ﹤0.01% 3209